drugset / Trial / NCT01275781

Study in Healthy Males to Assess Distribution, Metabolism, and Excretion of Radio-labelled AZD9742 Administered as a 2-hour Infusion

NCT01275781

Phase 1 Withdrawn AstraZeneca
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to assess distribution, metabolism, and excretion of radio-labelled AZD9742 administered as a 2-hour infusion to healthy male volunteers.

Timeline

Start
2011-01
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD9742 Unknown 1000 mg Intravenous

Indications

No indication recorded.